Cell therapy (Stem-cell derived) · developed by Mesoblast
NeoFuse is an adult stem cell-based implant, surgically placed in the spine.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT01106417 | Phase 1/2 | Cervical Degenerative Disc Disease | Completed | MESO |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Cervical Degenerative Disc DiseaseDegenerative SpondylolisthesisSpinal Stenosis
Updated Oct 18, 2026. Something wrong or missing? Report it on the MESO page.
See MESO's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
MESO catalysts and pipeline →